A POTENTIAL BIOMARKER FOR GLIOBLASTOMA?

Glioblastoma is a dangerous brain cancer known for its rapid growth and resistance to conventional treatments. Research are constantly underway to identify new management strategies, and recently, a novel biomarker named LCA168 has emerged as a potential avenue for GBM treatment. LCA168 is a protein that is abundantly produced in glioblastoma cell